Literature
首页医源资料库在线期刊美国临床营养学杂志2004年80卷第4期

Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Exacerbatedpostprandiallipemiaisariskfactorforcardiovasculardiseaseandislinkedtoinsulinstatus。Limiteddataontheeffectofdietarycarbohydrateonpostprandiallipoproteinaccumulationareavailable。Objective:Wetestedthehypothesisthatdietarycarbohydr......

点击显示 收起

Amandine Harbis, Sophie Perdreau, Stephanie Vincent-Baudry, Monique Charbonnier, Marie-Christine Bernard, Denis Raccah, Michele Senft, Anne-Marie Lorec, Catherine Defoort, Henri Portugal, Sophie Vinoy, Vincent Lang and Denis Lairon

1 From the UMR 476-INSERM/1260-INRA, Human Nutrition and Lipids, Faculty of Medecine, Université de la Méditerranée, Marseille, France (AH, SP, SV-B, MC, MS, CD, HP, and DL); the Department of Endocrinology, Diabetes, and Nutrition, La Timone University Hospital, Marseille, France (M-CB and DR); the Clinical Biochemistry Centre, Sainte Marguerite University Hospital, Marseille, France (A-ML, CD, and HP); and Danone Vitapole, Danone Group R & D Center, Palaiseau, France (SV and VL).

2 Supported by the Provence-Alpes-Cote d'Azur Regional Council and Danone Vitapole.

3 Reprints not available. Address correspondence to D Lairon, UMR U476-INSERM/INRA, Faculté de Medecine, 27 Boulevard Jean Moulin, 13885 Marseille Cedex 05, France. E-mail: denis.lairon{at}medecine.univ-mrs.fr.

See corresponding editorial on page 797.


ABSTRACT  
Background: Exacerbated postprandial lipemia is a risk factor for cardiovascular disease and is linked to insulin status. Limited data on the effect of dietary carbohydrate on postprandial lipoprotein accumulation are available.

Objective: We tested the hypothesis that dietary carbohydrates with different glucose availability alter postprandial lipoprotein metabolism differently in obese, insulin-resistant subjects.

Design: After an overnight fast, 9 subjects with central obesity and insulin resistance but normal triacylglycerolemia randomly ingested 2 test meals with comparable amounts of fat (28–29 g) and digestible carbohydrate (91–94 g) but with different quantities of slowly available glucose (SAG) in cereal products (17 or 2 g SAG/100 g for biscuits and wheat flakes, respectively). Blood samples were collected before and for 6 h after meal intakes.

Results: The postmeal 0–2-h areas under the curve (AUCs) for glycemia and insulinemia were significantly lower (P < 0.05) after the biscuit meal than after the flakes meal. Plasma triacylglycerol concentrations increased significantly after the flakes meal but not after the biscuit meal (1.5-fold higher 0–6-h AUC for the flakes meal). Apolipoprotein B-100 concentrations in the triacylglycerol-rich lipoprotein fraction increased significantly 2 h after the flakes meal but not after the biscuit meal (3-fold higher 0–6-h AUC for the flakes meal). Apolipoprotein B-48 concentrations increased (P < 0.05) 4 h after the flakes meal but not after the biscuit meal (2.3-fold higher 0–6-h AUC for the flakes meal).

Conclusion: Mixed meals containing slowly digestible carbohydrate that induces low glycemic and insulinemic responses reduce the postprandial accumulation of both hepatically and intestinally derived triacylglycerol-rich lipoproteins in obese subjects with insulin resistance.

Key Words: Test meals • carbohydrate • slowly digestible carbohydrate • glycemic index • lipemia • triacylglycerols • triacylglycerol-rich lipoproteins • cholesterol • apolipoprotein B-100 • apolipoprotein B-48 • glucose • insulin • cardiovascular disease


INTRODUCTION  
The healthy diet that is currently recommended in all industrialized countries to reduce the burden of cardiovascular disease is a low-fat, low-cholesterol, and high-carbohydrate diet. There is increasing interest in the effects of the amount and type of dietary carbohydrate on the metabolic profile and health-related issues, such as the metabolic syndrome and cardiovascular disease. Although the potential benefit of indigestible dietary fiber in such diets has generally been recognized, the effect of the kind of digestible carbohydrate is a matter of increasing concern (1-7). In fact, clinical studies indicate that highly digestible carbohydrate diets may lead to an elevation in fasting plasma triacylglycerol concentrations as a result of the accumulation of hepatic VLDL and chylomicron remnants due to altered lipoprotein secretion or clearance (3, 8, 9). Elevated fasting triacylglycerolemia and associated low HDL cholesterol are risk factors for cardiovascular disease (10). Moreover, epidemiologic studies have established a link between high dietary glycemic load and elevated cardiovascular risk (11). On the basis of the concept of the glycemic index (GI) (12), some clinical studies have shown that in comparison with high-GI diets, low-GI diets improve the metabolic profiles of healthy subjects (13, 14) and patients with type 2 diabetes, overweight subjects, and glucose-intolerant patients (15-19).

Given the observed general trends toward increased prevalences of obesity, the metabolic syndrome, and type 2 diabetes, the best, suitable diet for such patients is thus questioned (20, 21). In addition to other traits (22), altered postprandial lipoprotein metabolism is now an acknowledged feature of the metabolic syndrome (23-32) and type 2 diabetes (33, 34) and is involved in increased cardiovascular risk (35-39). A positive relation between fasting hyperinsulinemia and altered postprandial lipemia has been reported repeatedly (23-25, 27, 29, 31, 32, 34, 40), but the exact role of insulin in the regulation of postprandial lipemia still remains poorly understood, especially because insulin resistance and compensatory hyperinsulinism coexist in these patients. Both imbalances could play an important role in stimulating or repressing the expression of numerous genes and related metabolic pathways (3, 9). We recently showed that postprandial hyperinsulinemia (modulated by using different test meals or euglycemic-hyperinsulinic clamp) is a determinant of the late postprandial accumulation of intestinally derived apolipoprotein (apo) B-48–containing chylomicrons in healthy humans (41). This led us to suggest that postprandial hyperinsulinism could be particularly involved in the alteration of postprandial intestinal triacylglycerol-rich lipoprotein (TRL) metabolism whereas insulin resistance could be mainly responsible for altered hepatic TRL metabolism (3, 8, 9). We therefore anticipated that subjects with insulin resistance and elevated postprandial hyperinsulinemia would have postprandial alterations in both hepatic and intestinal lipoproteins. Thus, we designed the present study to test the hypothesis that sources of dietary carbohydrates with different slowly digestible carbohydrate contents could induce different glycemic and insulinemic responses that alter postprandial lipoprotein metabolism differently in insulin-resistant subjects.


SUBJECTS AND METHODS  
Subjects
Nine nondiabetic, android-type obese subjects (8 women with a waist circumference > 88 cm and 1 man with a waist circumference > 102 cm) with a mean age of 35 y (range: 25–45 y) were recruited after medical examination to participate in the study. Before participating in the study, all subjects gave their written informed consent to a protocol approved by the local Medical Ethics Committee (Comite Consultatif pour la Protection des Personnes se prêtant à des Recherches Bio-médicales, Marseille I). None of the subjects suffered from any digestive disease or were receiving any drug treatment that could influence carbohydrate or lipid metabolism. The subjects' mean (±SEM) body mass index (in kg/m2) was 36.4 ± 1.8, and the subjects' mean weight was 100 ± 3.7 kg. We aimed to select subjects with normal triacylglycerolemia to avoid too much imbalance in lipid metabolism. Mean fasting serum concentrations were as follows: glucose, 5.6 ± 0.2 mmol/L; insulin, 12.8 ± 1.5 mUI/L, or 88.2 ± 10.3 pmol/L; triacylglycerols, 1.1 ± 0.7 mmol/L; total cholesterol, 5.5 ± 0.4 mmol/L. All the selected subjects with central obesity had insulin resistance according to their homeostasis model assessment scores (42), with a mean value of 3.04 ± 0.3. As pointed out in other studies (43, 44), a strong negative correlation has been found between the homeostasis model assessment score and insulin sensitivity as checked by using a hyperinsulinic clamp in healthy subjects or patients with type 2 diabetes. The subjects were instructed to avoid alcohol consumption and intense exercise for 36 h before being tested and to consume a moderate amount of carbohydrates the day before the study. The subjects were asked to have a light standard dinner before 2100 on the evening before the experiment. The usual basal diet of each subject was monitored through the use of a 3-d food record during the first week of the experiment, and calculations were made with the GENI software package (Micro 6, Nancy, France). The subjects consumed a typical Western diet, with moderate energy consumption (mean: 9731 kJ/d, or 2328 kcal/d). Alcohol intake was negligible.

Test meals
Two different test meals were designed, and they differed essentially in the source of carbohydrate. The 2 test meals had similar energy content (2821 and 2871 kJ); had similar amounts of fat (29 and 28 g; 38% of energy), carbohydrates (94 and 91 g; 55% energy), and protein (18 and 24 g); and were composed of commercially available foods provided by Danone Vitapole (Palaiseau, France) (Table 1). The carbohydrate sources compared were cereal foods: experimental plain wheat biscuits (biscuit meal) and usual ready-to-eat wheat flakes (flakes meal). The cereal products were processed differently, which led to different contents of slowly available glucose (SAG; 17 g SAG/100 g compared with 2 g SAG/100 g for the biscuit and the flakes meals, respectively; reference 45); however, the carbohydrate contents of the 2 meals were similar [72% (wt:wt) and 78% (wt:wt) for the biscuit and the flakes meals, respectively]. The SAG content has been negatively correlated with GI (45).


View this table:
TABLE 1. Food composition and nutrient and energy contents of the 2 test meals1

 
The fat was provided in the form of a biscuit, flakes, yogurt, soft cheese, or milk and as palm oil homogenized in dairy products (Table 1). Most fatty acids were saturated (saturated fatty acids: 53.1% and 56.2% in the biscuit and the flakes meals, respectively; monounsaturated fatty acids: 37.4% and 36.3% in the biscuit and the flakes meals, respectively; polyunsaturated fatty acids: 9.5% and 7.5% in the biscuit and the flakes meals, respectively).

Each subject ingested the 2 test meals in a random order in the outpatient metabolic ward (Department of Endocrinology, Diabetes, and Nutrition, La Timone University Hospital, Marseille, France); the 2 test meals were separated by a 1-wk interval. After the subjects had fasted overnight, an antecubital vein was catheterized with intravenous cannulae equipped with disposable obturators (Jelco-Critikon, Chatenay-Malabry, France). A baseline (0 h) fasting blood sample was collected. Then the subjects ingested the test meal within 20 min. The countdown was fixed at the middle of food intake. Blood samples were collected every half hour during the first 2 h and every hour until 6 h after the meal as described previously (25, 41, 46).

Analytic determinations
Plasma and serum were immediately separated from whole blood by centrifugation (910 x g, 10°C, 10 min). Plasma glucose, triacylglycerol, total cholesterol, HDL-cholesterol, and LDL-cholesterol concentrations were measured by using an enzymatic procedure with commercial kits (Bhringer Mannheim, Meylan, France) as described previously (41). Insulin concentrations were measured by using an immunoenzymatic method with commercial kits (Bhringer Mannheim). Nonesterified fatty acid concentrations were measured by using an enzymatic colorimetric procedure with kits purchased from Randox (Amtrim, United Kingdom).

The chylomicron fraction (Sf > 400) was isolated from 1.5 mL plasma layered under 1.5 mL NaCl (9.0 g/L) by ultracentrifugation (33810 x g, 15°C, 6 min) with the use of a Beckman TLX100 ultracentrifuge (Palo Alto, CA) and a 100.3 rotor as previously reported (25). The TRL fraction (Sf > 20; chylomicron plus VLDL) was isolated from 1.5 mL plasma layered under 1.5 mL NaCl (9.0 g/L) by ultracentrifugation (540960 x g, 15°C, 160 min). LDL and HDL particles were then isolated by sequential ultracentrifugation (41). Triacylglycerols and cholesterol were assayed in lipoprotein fractions by using an enzymatic procedure with commercial kits. Chylomicron sizes were measured at 20°C on suspended, freshly prepared samples by using photon correlation spectroscopy with a particle-sizer analyzer (SEMATech, Nice, France) as described previously (25).

Apo B-48 and apo B-100 were assayed by using enzyme-linked immunosorbent assay methods as described previously (41, 47). Briefly, assessment of apo B-48 was performed by using a competitive enzyme-linked immunosorbent assay with a specific apo B-48 antibody obtained in rabbits. A 96-well microtiter plate (Maxisorp; Nunc, Polylabo, France) was coated with a C-terminal apo B-48–specific heptapeptide. Plasma samples were incubated with Triton X-100 (Euromedex, Souffelweyersheim, France) to allow competition between immobilized antigen and plasma apo B-48. Apo B-48–containing chylomicrons were used as the standard. Peroxidase-labeled anti-rabbit immunoglobulins and their substrates allowed color development.

Assessment of apo B-100 in TRL was performed by using a noncompetitive sandwich enzyme-linked immunosorbent assay. Briefly, a 96-well microtiter plate was coated with 2G8 monoclonal anti–apo B-100 antibody (Mona, Moscow), which does not cross-react with apo B-48 (48). TRL samples were added, and the apo B-100–containing VLDLs that reacted with the monoclonal antibody were quantified after the addition of first an anti–apo B-100 polyclonal antibody (Calbiochem, Meudon, France) and then of peroxidase-labeled immunoglobulins. The color was developed and measured as described above. Apo B-100–containing LDLs were used as the standard.

After the 6-h postprandial blood sampling, each subject was injected with 80 IU heparin/kg (Choay, Gentilly, France). A postheparin blood sample was drawn after 10 min for subsequent determination of lipoprotein lipase and hepatic lipase activities as reported previously (41).

Statistical analysis
In this randomized study, each subject ingested the 2 test meals and served as his or her own control. Results are given as means ± SEMs. Absolute postprandial changes are given as concentration values. The 0–2-h and 0–6-h areas under the curve (AUCs) were calculated from incremental postprandial variations (postprandial values minus baseline value) by using the trapezoidal method. The data could not be normalized, and thus we used nonparametric tests. The statistical significance (P < 0.05) of the meal effect was assessed by using the Wilcoxon test for nonparametric values. In each meal group, the time effect during the postprandial period was assessed by using repeated-measures analysis with the nonparametric Friedman test for global interaction; when the interaction was significant, detailed comparisons were performed by using the Wilcoxon test (SPSS 11.5 for WINDOWS; SPSS Inc, Chicago).


RESULTS  
Ingestion of the 2 test meals significantly increased glycemia as shown in Figure 1 A. Glycemia increased significantly (P < 0.05) 30 min after meal ingestion and was significantly higher after the flakes meal than after the biscuit meal (7.61 ± 0.57 compared with 6.36 ± 0.36 mmol/L). The incremental 0–2-h AUC for glycemia (Figure 1A, inset) was significantly higher after the flakes meal than after the biscuit meal (1.41 ± 0.58 compared with 0.77 ± 0.28 mmol · h/L).


View larger version (41K):
FIGURE 1.. Mean (±SEM) postprandial changes in metabolic variables during 6 h after ingestion of a biscuit meal ( in insets) (n = 9). A: Plasma glucose concentrations and 0–2-h and 0–6-h incremental areas under the curve (AUCs) (inset); B: plasma insulin concentrations and 0–2-h and 0–6-h incremental AUCs (inset); C: plasma triacylglycerol concentrations and 0–6-h incremental AUCs (inset); D: triacylglycerol-rich lipoprotein (TRL) apolipoprotein (apo) B-100 concentrations and 0–6-h incremental AUCs (inset); E: plasma apo B-48 concentrations and 0–6-h incremental AUCs (inset); F: plasma nonesterified fatty acid (NEFA) concentrations and 0–6-h incremental AUCs (inset). *Significant difference between the biscuit meal and the flakes meal, P < 0.05 (Wilcoxon test for nonparametric values). There was a significant (P < 0.05) meal  
Insulinemia increased significantly 30 min after ingestion of the 2 test meals, and significantly higher insulin concentrations were observed 1 and 1.5 h after the flakes meal than after the biscuit meal (Figure 1B). As shown in the inset of Figure 1B, the incremental insulin postprandial response was significantly higher after the flakes meal than after the biscuit meal from 0 to 2 h (AUC: 773.8 ± 139.1 compared with 482.6 ± 78.8 pmol · h/L) and from 0 to 6 h (AUC: 1109.7 ± 169.2 compared with 737.5 ± 124.1 pmol · h/L).

As shown in Figure 1C, triacylglycerolemia increased significantly 1 h after the flakes meal, and significantly higher peak concentrations were observed after the flakes meal than after the biscuit meal from 1 h (1.41 ± 0.18 compared with 1.03 ± 0.14 mmol/L) up to 4 h (1.25 ± 0.13 compared with 0.99 ± 0.3 mmol/L). The incremental 0–6-h AUC for plasma triacylglycerols was significantly higher after the flakes meal than after the biscuit meal (Figure 1C, inset). Incremental 0–6-h AUC values for TRL triacylglycerols (1.10 ± 0.39 and 1.28 ± 0.53 mmol · h/L for the biscuit and the flakes meals, respectively) and chylomicron triacylglycerols (0.56 ± 0.22 and 0.62 ± 0.24 mmol · h/L for the biscuit and the flakes meals, respectively) were not markedly different after the 2 test meals. Mean chylomicron sizes increased from 60 nm at baseline to 100–120 nm 2–4 h after meal intake but decreased after 6 h; there were no significant differences in chylomicron sizes between the 2 test meals (data not shown).

After ingestion of the 2 meals, different postprandial patterns were observed for TRL apo B-100 and chylomicron apo B-48. Apo B-100 concentrations in the TRL fraction increased significantly after the flakes meal but not after the biscuit meal and peaked 2 h after meal ingestion (Figure 1D). At this time point, the mean TRL apo B-100 concentration after the flakes meal was significantly higher than that after the biscuit meal. For longer periods of time (3–6 h), apo B-100 concentrations did not differ significantly from baseline, and no further significant differences between the meals were found. The incremental 0–3-h (data not shown) and 0–6-h (Figure 1D, inset) AUCs for TRL apo B-100 were 6.31- and 3.05-fold higher (P < 0.05), respectively, after the flakes meal than after the biscuit meal. Postprandial changes in plasma apo B-48 concentrations are shown in Figure 1E. Apo B-48 concentrations did not change noticeably after the biscuit meal but increased markedly after the flakes meal, and significantly higher peak values were observed 4 h after the flakes meal than after the biscuit meal. The incremental 0–6-h (Figure 1E, inset) and 3–6-h (data not shown) AUCs for apo B-48 were 2.3- and 3.4-fold higher (P < 0.05), respectively, after the flakes meal than after the biscuit meal.

After ingestion of the 2 test meals, plasma total cholesterol concentrations did not show a significantly different negative trend (0–6-h AUC: –3.79 ± 0.39 and –4.46 ± 0.97 mmol · h/L after the biscuit and the flakes meals, respectively). Similarly, LDL-cholesterol (0–6-h AUC: –2.97 ± 0.31 and –3.34 ± 0.75 mmol · h/L after the biscuit and the flakes meals, respectively) and HDL-cholesterol (0–6-h AUC: –1.16 ± 0.12 and –1.25 ± 0.21 mmol · h/L after the biscuit and the flakes meals, respectively) concentrations did not differ significantly between the 2 test meals.

Plasma nonesterified fatty acid concentrations (Figure 1F) decreased significantly 1–4 h after the intake of each test meal but progressively returned to the baseline value after 5 h. No significant differences between the responses to the 2 meals were observed.

Lipoprotein lipase and hepatic lipase activities were determined in postheparin plasma 6 h after meal intake. No significant differences in enzyme activities after the biscuit and the flakes meals were observed (mean lipoprotein lipase activity: 0.99 ± 0.15 and 0.93 ± 0.23 µmol · h–1 · mL–1, respectively; mean hepatic lipase activity: 0.57 ± 0.09 and 0.66 ± 0.07 µmol · h–1 · mL–1, respectively).


DISCUSSION  
In the present study, we tested the hypothesis that subjects with central obesity and some degree of insulin resistance have postprandial alterations in both hepatic and intestinal lipoproteins that are influenced by the glycemic and insulinemic responses to a meal. We found that in comparison with ingestion of a mixed meal rich in rapidly available glucose, ingestion of a meal rich in SAG lowered both the postprandial increase in insulinemia and the accumulation of circulating triacylglycerols and apo B-100–or apo B-48–containing TRL in those subjects.

The carbohydrate-rich foods provided by the 2 test meals contained markedly different amounts of SAG (17% in the flakes meal compared with 2% in the biscuit meal). As expected, the 2 mixed meals tested elicited markedly different glycemic responses, with a 1.8-fold higher increase in the plasma glucose 0–2-h AUC after the flakes meal than after the biscuit meal. In addition, the observed 0–2-h insulin postprandial response was 1.6-fold higher (P < 0.05) after the flakes meal than after the biscuit meal, which is in agreement with previous data showing that meals containing slowly digestible carbohydrates induce lower glycemic and insulinemic responses (45, 49).

The 2 different levels of postprandial hyperinsulinemia elicited by the 2 meals were accompanied by 2 different patterns for plasma lipids and lipoproteins. After the high-SAG biscuit meal, plasma triacylglycerols, TRL triacylglycerols, TRL apo B-100, and plasma apo B-48 showed low-to-moderate postprandial increases, as a likely response of normolipidemic subjects to the moderate amount (29 g) of fat provided by the test meal (47). In contrast, after the flakes meal, which was rich in rapidly available glucose and provided the same amount of fat, we observed exaggerated accumulations of plasma triacylglycerols, TRL apo B-100, and chylomicron apo B-48. Similar figures for plasma triacylglycerols and apo B-48 but not for apo B-100 were observed previously in healthy subjects after meals with different amounts or types of carbohydrate (41, 50). Other data obtained after the addition of glucose to fatty test meals have not been reproduced in healthy subjects (51). Moreover, in moderately overweight, nondiabetic men, ingestion of breakfasts with either high- or low-GI foods (detailed composition unknown) did not lead to differences in postprandial changes in triacylglycerol concentrations (17).

TRL particles that accumulate in the circulation after fatty meals are known to be of both hepatic and intestinal origin due to superimposition of the 2 secretory pathways (25, 32, 52). It is thus interesting to observe that the flakes meal, which elicited higher glycemic and insulinemic responses than did the biscuit meal, exacerbates the accumulation of apo B-100–containing TRL and plasma chylomicron apo B-48 postprandially. This indicates that the increase in triacylglycerol concentrations observed in plasma or lipoprotein fractions is, at least partly, a reflection of an increased number of lipoprotein particles present in the circulation postprandially. Another interesting finding was that the postprandial accumulation of apo B-100–and apo B-48–containing TRLs showed different time courses. A biphasic postprandial accumulation of TRL triacylglycerols was observed previously after high-carbohydrate meals but not after low-carbohydrate meals in healthy subjects (50). The observed early accumulation (2-h peak) of TRL apo B-100 (a marker of hepatically derived VLDL) in the plasma after the high-GI flakes meal may have resulted from the generated acute hyperinsulinism superimposed on a preexisting insulin-resistant state. Indeed, insulin resistance has been shown to weaken the repressive effect of insulin on hepatic VLDL secretion (8, 29, 30, 53), whereas postprandial hyperinsulinism does not generate any marked accumulation of apo B-100–containing TRL postprandially in healthy subjects (41). Another possibility is that a worsened repression of chylomicron concentrations by insulin, as observed in healthy subjects (41), leads to an early relative increase in chylomicron number that is preferentially cleared and therefore generates a more marked accumulation of VLDL at that time.

In fact, the insulin resistance–hyperinsulinism state is usually associated with fasting hypertriacylglycerolemia and hyperVLDLemia in patients (23-25, 27-32, 34, 40), and both of these phenomena are stimulated by chronic high-carbohydrate feeding (3, 33, 54). Because fasting triacylglycerolemia is a known determinant of postprandial triacylglycerolemia, one can anticipate that much more marked and prolonged postprandial accumulation of apo B-100–containing TRL would occur in frankly hypertriglyceridemic, insulin-resistant subjects (25). This remains to be tested.

In addition, accumulation of a greater number of intestinal apo B-48–containing chylomicrons was observed after the flakes meal than after the biscuit meal, and a major late peak occurred at 4 h with the flakes meal. Such a late chylomicron apo B-48 peak has been observed in healthy subjects after high-GI meals only or after a euglycemic-hyperinsulinemic clamp (41) and in patients with type 2 diabetes (34). Alterations in intestinally derived lipoprotein secretion or clearance may explain these observations. Regarding secretion, some recent evidence indicates that dietary glucose may stimulate intestinal resecretion and the occurrence in plasma of triacylglycerols or cholesterol in triacylglycerol-rich particles (55, 56). Apparently contradictorily, we suggested from previous data in healthy subjects (41) that hyperinsulinism could delay the secretion of intestinal TRL, as already stated for the liver (57). Some limited experimental data support such an insulin-mediated inhibition of or delay in intestinal lipid secretion (58; A Harbis and D Lairon, unpublished observations, 2000). Thus, through a direct effect of glucose or an effect of induced hyperinsulinemia, meals rich in rapidly available glucose may noticeably alter intestinal secretion of chylomicrons, which may lead to an amplified and late accumulation of these particles and their remnants in the circulation after a meal; this possibility would account for the observations made in the present study. Nevertheless, the possible combined effect of insulin resistance and hyperinsulinism in this process is not known, and further studies are needed to firmly establish such mechanisms.

Regarding intestinal chylomicron clearance, one can suggest that the 2.3-fold higher apo B-48 AUC after the flakes meal than after the biscuit meal in the insulin-resistant subjects could have resulted from exacerbated competition for clearance between apo B-100–containing TRL particles (VLDL) and apo B-48–containing chylomicrons in the postprandial period, in which intestinal secretion dramatically increases after the digestion and absorption of meal fat. Finally, insulin is known to stimulate lipoprotein lipase activity in adipose tissue, an effect blunted in glucose-intolerant, obese subjects (59). This would explain the fact that the 2 meals did not induce noticeable differences in postheparin plasma activities. Men and women with central obesity and insulin resistance are known to have elevated concentrations of both apo B-100–and apo B-48–containing TRLs in the fasting state (25, 29, 32, 34, 41, 53) that mirror well the elevated postprandial concentrations observed in the present study and some others studies (25, 29, 32, 34). Indeed, the present data obtained in normolipidemic subjects with central obesity and some degree of insulin resistance suggest that superimposition of dietarily induced, acute, important postprandial hyperinsulinemia onto a preexisting insulin-resistant state generates an exacerbated accumulation of postprandial TRLs originating from the liver and intestine. This would favor the residual accumulation of both liver and intestinal TRL particles in the fasting state, which would account for the fasting hypertriacylglycerolemia that is involved in the metabolic syndrome (22) and associated with increased cardiovascular risk (10). In contrast, low-fat meals rich in slowly available carbohydrates did not elicit such a detrimental postprandial pattern in these subjects in the present study.


ACKNOWLEDGMENTS  
DL conceived and designed the study, obtained financial support, discussed the data, and wrote the manuscript. M-CB and DR recruited the subjects. DR discussed the study design, managed the metabolic ward, and corrected the manuscript. AH and SP performed the daily work and part of the biochemical analyses. MS, A-ML, CD, and HP performed analyses and/or supervised biochemical analyses. AH, SV-B, and MC performed the data analysis. SV and VL provided advice and food-composition data and manufactured foods for the study.


REFERENCES  

  1. Reaven GM. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997;8:23–7.
  2. Katan MB, Grundy SM, Willett WC. Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. N Engl J Med 1997;337:563–6.
  3. Parks EJ. Effect of dietary carbohydrate on triglyceride metabolism in humans. J Nutr 2001;131:2772S–4S.
  4. Jenkins DJA, Kendall CWC, Augustin LSA, Vuskan V. High-complex carbohydrate or lente carbohydrate foods? Am J Med 2002;113:30S–7S.
  5. Anderson JW, Major AW. Pulses and lipaemia, short- and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr 2002;88(suppl):263–71.
  6. Hung T, Sievenpiper JL, Marchie A, Kendall CW, Jenkins DJ. Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2003;6:165–76.
  7. McCullough ML, Feskanich D, Stampfer MJ, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 2002;76:1261–71.
  8. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84:28J–32J.
  9. Roche HM. Dietary carbohydrate and triacylglycerol metabolism. Proc Nutr Soc 1999;58:201–7.
  10. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213–9.
  11. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000;71:1455–61.
  12. Jenkins DJA, Wolever TMS, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362–6.
  13. Jenkins DJA, Wolever TMS, Collier Gr, et al. Metabolic effects of a low-glycemic-index diet. Am J Clin Nutr 1987;46:968–75.
  14. Behall KM, Scholfield DJ, Yuhaniak I, Canary J. Diets containing high amylose vs amylopectin starch: effects on metabolic variables in human subjects. Am J Clin Nutr 1989;49:337–44.
  15. Wolever TM, Jenkins DJ, Vuksan V, Jenkins AL, Wong GS, Josse RG. Beneficial effect of low-glycemic index diet in overweight NIDM subjects. Diabetes Care 1992;15:562–4.
  16. Frost G, Keogh B, Smith D, Akinsanya K, Leeds A. The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 1996;45:669–72.
  17. Bouché C, Rizkalla SW, Luo J, et al. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 2002;25:822–8.
  18. Kabir M, Oppert J-M, Vidal H, et al. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002;51:819–26.
  19. Wolever TMS, Mehling C. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 2003;77:612–21.
  20. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074–81.
  21. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003;157:773–9.
  22. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607.
  23. Jeppesen J, Hollenbeck CB, Zhou MY, et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma, lipoprotein lipase activity and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995;15:320–4.
  24. Couillard C, Bergeron N, Prud'homme D, et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998;47:953–60.
  25. Mekki N, Chritophilis MA, Charbonnier M, et al. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J Clin Endocrinol Metab 1999;84:184–91.
  26. Vansant G, Mertens A, Muls E. Determinants of postprandial lipemia in obese women. Int J Obes Relat Metab Disord 1999;23:14–21.
  27. Guerci B, Vergès B, Durlach V, Hadjadj S, Droiun P, Paul J-L. Relationship between altered posprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 2000;24:468–78.
  28. Mamo JCL, Watts GF, Barrett HR, Smith D, James AP, Pal S. Posprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol 2001;281:E626–32.
  29. Kim H-S, Abbasi F, Lamendola C, MCLaughlin T, Reaven GM. Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenoposal women. Am J Clin Nutr 2001;74:592–5.
  30. Frayn KN. Insulin resistance, impaired posprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 2002;11(suppl):31–40.
  31. Chan DC, Watts GF, Barrett PH, Mamo JC, Redgrave TG. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem 2002;48:278–83.
  32. Lovegrove JA, Silva KD, Wright JW, Williams CM. Adiposity, insulin and lipid metabolism in post-menopausal women. Int J Obes Relat Metab Disord 2002;26:475–86.
  33. Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM. Effect of variations in dietary fat and carbohydrate intake on postprandial lipemia in patients with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 1993;76:347–51.
  34. Curtin A, Deegan P, Ovens D, Collins P, Johnson A, Tomkin GH. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotien B-48. Acta Diabetol 1996;33:205–10.
  35. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473–85.
  36. Karpe F, Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1995;6:123–9.
  37. Mero N, Malström R, Steiner G, Taskinen M-R, Syvänne M. Postprandial metabolism of apolipoprotein B-48- and B-100–containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000;15:167–77.
  38. Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001;47:111–36.
  39. Roche HM, Gibney MJ. The impact of postprandial lipemia in accelerating atherothrombosis. J Cardiovasc Risk 2000;7:315–24.
  40. Boquist S, Hamsten A, Karpe F, Ruotolo G. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men. Diabetologia 2000;43:185–93.
  41. Harbis A, Defoort C, Narbonne H, et al. Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period. Diabetes 2001;50:462–9.
  42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
  43. Skrha J, Haas T, Sindelka G, et al. Comparison of the hyperinsulinemic clamps with homeoastasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab 2004;89:135–41.
  44. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57–63.
  45. Englyst KN, Vinoy S, Englyst HN, Lang V. Glycaemic index of cereal products explained by their content of rapidly and slowly available glucose. Br J Nutr 2003;89:329–39.
  46. Dubois C, Beaumier G, Juhel C, et al. Effects of graded amounts (0–50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. Am J Clin Nutr 1998;67:31–8.
  47. Lorec AM, Juhel C, Pafumi Y, et al. Determination of apolipoprotein B-48 by a competitive ELISA. Clin Chem 2000;46:1638–42.
  48. Kosykh VA, Novikov DK, Trakht IN, et al. Effect of chylomicron remnants on cholesterol metabolism in cultured rabbit hepatocytes: very low density lipoprotein and bile acid production. Lipids 1991;26:799–805.
  49. Bjorck I, Liljeberg H, Ostman E. Low glycemic-index foods. Br J Nutr 2000;83:S149–55.
  50. Shishehbor F, Roche HM, Gibney MJ. The effect of acute carbohydrate load on the monophasic or biphasic nature of the postprandial lipaemic response to acute fat digestion in human subjects. Br J Nutr 1998;80:411–8.
  51. Cohen JC, Schall R. Reassessing the effects of simple carbohydrates on the serum triglyceride responses to fat meals. Am J Clin Nutr 1988;48:1031–4.
  52. Cohn JS, Johnson EJ, Millar JS, et al. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoprotein (TRL) to postprandial increases in plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993;34:2033–9.
  53. Zamit VA. Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance. Ann N Y Acad Sci 2002;967:52–65.
  54. Parks ES, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effect of low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 1999;104:1087–96.
  55. Robertson MD, Parkes M, Warren BF, et al. Mobilisation of enterocyte fat stores by oral glucose in humans. Gut 2003;52:834–9.
  56. Play B, Salvini S, Haikal Z, et al. Glucose and galactose regulate intestinal absorption of cholesterol. Biochem Biophys Res Commun 2003;310:11–8.
  57. Malmström R, Packard CJ, Watson TD, et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997;17:1454–64.
  58. Levy E, Sinnett D, Thibault L, Nguyen TD, Delvin E, Ménard D. Insulin modulation of newly synthesized apolipoproteins B-100 and B-48 in human fetal intestine: gene expression and mRNA editing are not involved. FEBS Lett 1996;393:253–8.
  59. Coppack SW, Evans RD, Fisher RM, et al. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992;41:264–72.
Received for publication December 22, 2003. Accepted for publication April 27, 2004.


Related articles in AJCN:

Carbohydrates and the postprandial state: have our cake and eat it too?
David S Ludwig and David J Jenkins
AJCN 2004 80: 797-798. [Full Text]  

作者: Amandine Harbis
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具